RELATED CONTENT
NEWS
- New analysis seeks to find mutations that predict response to Amgen's Vectibix in colorectal cancer
- Vectibix recommended for colorectal cancer in Japan
- Amgen's Vectibix fails to show survival benefit in pivotal first-line trial in colorectal cancer
- Mixed Phase III results for Erbitux in first-line colorectal cancer


